ABG Analytics logo
 

Amgen Inc (NASDAQ: AMGN)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 03/15/2024
Closing price: 268.87
Support price level: N/A
Resistance price level: $275.01
Relative strength index (14-day RSI) 26.9
Beta 0.46
  • AMGN is one of this month's worst performers with a return of -7.0%, underperforming 90 percent of stocks in the S&P-100.

  • Volatility is forecast to fall over the next month.

  • With RSI < 30, AMGN is oversold. Odds slightly favor a short-term price reversal.

  • Price broke below prior support level - a short-term bearish signal.

Low High Price as % of Range
$214.27 $324.56 54.7%
200 day 50 day 20 day 10 day
$265.68 $294.98 $278.45 $274.75
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
25.3% 29.7% 22.4% 24.0%
There is an estimated 5% probability that the stock price of Amgen Inc will fall by more than:
  • 6.1% in the next week.

  • 13.6% in the next month.

  • 42.2% in the next year.